Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
336.12
-3.63 (-1.07%)
Oct 27, 2025, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Employees
Bio-Rad Laboratories had 7,700 employees as of December 31, 2024. The number of employees decreased by 330 or -4.11% compared to the previous year.
Employees
7,700
Change (1Y)
-330
Growth (1Y)
-4.11%
Revenue / Employee
$331,714
Profits / Employee
$41,455
Market Cap
9.10B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7,700 | -330 | -4.11% |
| Dec 31, 2023 | 8,030 | -170 | -2.07% |
| Dec 31, 2022 | 8,200 | 300 | 3.80% |
| Dec 31, 2021 | 7,900 | -100 | -1.25% |
| Dec 31, 2020 | 8,000 | -120 | -1.48% |
| Dec 31, 2019 | 8,120 | -140 | -1.69% |
| Dec 31, 2018 | 8,260 | 110 | 1.35% |
| Dec 31, 2017 | 8,150 | -100 | -1.21% |
| Dec 31, 2016 | 8,250 | 480 | 6.18% |
| Dec 31, 2015 | 7,770 | 170 | 2.24% |
| Dec 31, 2014 | 7,600 | -150 | -1.94% |
| Dec 31, 2013 | 7,750 | 370 | 5.01% |
| Dec 31, 2012 | 7,380 | 350 | 4.98% |
| Dec 31, 2011 | 7,030 | 150 | 2.18% |
| Dec 31, 2010 | 6,880 | 280 | 4.24% |
| Dec 31, 2009 | 6,600 | 0 | - |
| Dec 31, 2008 | 6,600 | 200 | 3.13% |
| Dec 31, 2007 | 6,400 | 1,000 | 18.52% |
| Dec 31, 2006 | 5,400 | 200 | 3.85% |
| Dec 31, 2005 | 5,200 | 0 | - |
| Dec 31, 2004 | 5,200 | 400 | 8.33% |
| Dec 31, 2003 | 4,800 | 200 | 4.35% |
| Dec 31, 2002 | 4,600 | 300 | 6.98% |
| Dec 31, 2001 | 4,300 | 500 | 13.16% |
| Dec 31, 2000 | 3,800 | -300 | -7.32% |
| Dec 31, 1999 | 4,100 | 1,425 | 53.27% |
| Dec 31, 1998 | 2,675 | 25 | 0.94% |
| Dec 31, 1997 | 2,650 | 115 | 4.54% |
| Dec 31, 1996 | 2,535 | 75 | 3.05% |
| Dec 31, 1995 | 2,460 | 130 | 5.58% |
| Dec 31, 1994 | 2,330 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BIO News
- 3 days ago - Compelling Value In Small-Cap Equities And Select Cyclicals - Seeking Alpha
- 4 days ago - 7 Stocks Taking The Next Step To Be On Offense - Seeking Alpha
- 6 days ago - It's time to scoop up undervalued stocks in this critical sector of the economy - Market Watch
- 11 days ago - Bio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025 - Business Wire
- 7 weeks ago - Biorad Medisys announces its entry into the US market with the launch of its new subsidiary Medtimo Inc. - GlobeNewsWire
- 7 weeks ago - Bio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript) - Seeking Alpha
- 2 months ago - Bio-Rad's Management to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause - Seeking Alpha